We specialize in developing novel modalities that are designed to address the limitations of traditional treatments. Leveraging cutting-edge AI technologies we created advanced workflows tailored for each therapeutic strategy, accelerating the discovery and optimization of novel therapeutic candidates.
We design monospecific small molecules and peptides for any protein target and indication:
Wide range of bispecific compounds could be designed with the warheads targeting any target protein:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Our technologies allows modulating protein-protein interactions in different ways even in the most challenging cases:
We provide a workflow for designing peptides and small molecule functional mimetics of antibodies with superior ADMET properties and oral administration:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.